This NLRP3 activity was shown to be regulated by IL-1 receptor antagonist (IL-1RA) in a negative feedback loop, thereby providing a potential therapeutic angle to attenuate CF airway disease by chronic colonization [108]. Here, NLRP3 is linked to cystic fibrosis.